Guest
🎯 Загружено автоматически через бота: 🚫 Оригинал видео: 📺 Данное видео принадлежит каналу «CNBC Television» (@CNBCtelevision). Оно представлено в нашем сообществе исключительно в информационных, научных, образовательных или культурных целях. Наше сообщество не утверждает никаких прав на данное видео. Пожалуйста, поддержите автора, посетив его оригинальный канал. ✉️ Если у вас есть претензии к авторским правам на данное видео, пожалуйста, свяжитесь с нами по почте support@, и мы немедленно удалим его. 📃 Оригинальное описание: Operation Warp Speed chief advisor Dr. Moncef Slaoui has submitted his resignation at the request of the incoming Biden team under a plan that would see him stay in the role for a month to help with the transition, according to two people familiar with the situation. He joined “Squawk Box“ and CNBC’s Meg Tirrell on Wednesday to discuss his resignation. For access to live and exclusive video from CNBC subscribe to CNBC PRO: Operation Warp Speed chief advisor Dr. Moncef Slaoui has submitted his resignation at the request of the incoming Biden team under a plan that would see him stay in the role for a month to help with the transition, according to two people familiar with the situation. Slaoui’s role leading vaccine development for the unprecedented government effort is expected to be diminished after next Wednesday’s inauguration, said the people, who spoke on condition of anonymity because the plan wasn’t announced. It would end by Feb. 12. It’s not clear who will take scientific lead for the Biden team focused on Covid vaccines or if someone will be appointed to that role. Two vaccines are already authorized in the U.S. and three more are in late-stage clinical trials. Jeff Zients is Biden’s coordinator of the Covid-19 response, while Bechara Choucair will be Covid vaccine coordinator, focused on speeding inoculations. Slaoui’s contract includes 30 days’ notice before termination, and the Biden team has not asked Slaoui to stay on past that, one of the people said. Slaoui had said he planned to step down after two vaccines and two therapies for Covid reached the market, which happened last month with the clearance of Moderna’s vaccine. Last week, he said he “decided to extend that in order to ensure that the operation continues to perform the way it has performed through the transition of administration.” He noted though that “we’re getting close to the point where my value add is more limited.” Though the initial vaccine rollout has been criticized, the speed of their development, which Slaoui oversaw, exceeded expectations: Two vaccines have been authorized in the U.S. with 95% efficacy in preventing disease, from Pfizer and Moderna. Pivotal results from Johnson & Johnson on its vaccine, the first offering the potential for just one dose, are expected within weeks. It was the fastest vaccine development in history. Slaoui was criticized when he took the job for his ties to the pharmaceutical industry; he resigned from the board of Moderna around the time his role was announced. He sold his shares in the company and said he donated their increase in value during the few days he held them while at the Operation Warp Speed helm. He declined, though, to sell his shares in GlaxoSmithKline, where he spent 30 years and oversaw vaccine development, calling the stock his retirement. He was criticized in particular by Sen. Elizabeth Warren, and responded to her in September in a video message, saying he’s a registered Democrat, but “didn’t hesitate” to take the role “because this pandemic is bigger than any one of us.” Slaoui was paid $1,000 for his work overseeing Operation Warp Speed, which he said he planned to donate to scientific research. » Subscribe to CNBC TV: » Subscribe to CNBC: » Subscribe to CNBC Classic: Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: Connect with CNBC News Online Get the latest news: Follow CNBC on LinkedIn: Follow CNBC News on Facebook: Follow CNBC News on Twitter: Follow CNBC News on Instagram: #CNBC #CNBCTV
